
Celgene and bluebird bio work together on gene therapy for cancer
Executive Summary
Celgene Corp. and bluebird bio LLC (gene therapies for genetic and orphan diseases) have teamed up to discover new cancer treatments that utilize a patient’s own T-cells.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
- Immuno-Oncology
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com